Welcome to LookChem.com Sign In|Join Free
  • or
norethisterone-3-oxime is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

23965-86-8

Post Buying Request

23965-86-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23965-86-8 Usage

Uses

Hormone.

Hazard

A reproductive hazard.

Check Digit Verification of cas no

The CAS Registry Mumber 23965-86-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,9,6 and 5 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 23965-86:
(7*2)+(6*3)+(5*9)+(4*6)+(3*5)+(2*8)+(1*6)=138
138 % 10 = 8
So 23965-86-8 is a valid CAS Registry Number.
InChI:InChI=1/C20H27NO2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21-23)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18,22-23H,4-11H2,2H3/b21-14+/t15-,16+,17+,18-,19-,20-/m0/s1

23965-86-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (3E,8R,9S,10R,13S,14S,17R)-17-ethynyl-3-hydroxyimino-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol

1.2 Other means of identification

Product number -
Other names Norethindrone 3-oxime

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23965-86-8 SDS

23965-86-8Upstream product

23965-86-8Downstream Products

23965-86-8Relevant academic research and scientific papers

COMPOUNDS FOR TARGETED THERAPIES OF CASTRATION RESISTANT PROSTATE CANCER

-

Paragraph 00131; 00132, (2020/09/12)

The present invention generally relates to new compounds for therapeutic uses. In particular, this disclosure relates to novel tetracyclic compounds useful for treatment of cancer, especially castration resistant prostate cancer. Pharmaceutical composition matters and methods for treating a cancer patient by administering therapeutically effective amounts of such compound alone or together with other therapeutics are within the scope of this disclosure.

Prolonged release of antifertility drugs

-

, (2008/06/13)

Antifertility drug complexes which have enhanced effectiveness and prolonged release of the antifertility drug. The complex includes an antifertility drug, a polybasic acid and a polyvalent metal ion. The antifertility drug is in the form of a basic amine derivative.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 23965-86-8